Studies show strong links between the endocrine system and COVID-19 incidence and mortality

September 14, 2020

COVID-19 and interlinkages to endocrine and metabolic diseases was an important programme topic at the 2020 European Congress of Endocrinology. With 4675 attendees from 112 countries this is the premier European endocrine meeting. Over 5 days, panel sessions covered the science behind COVID-19 and endocrine and metabolic disorders, as well as e-consulting and e-support to endocrine patients in times of COVID-19.

"One thing that is clear from the beginning of the pandemic is that patients with underlying endocrine diseases, like diabetes, obesity or the lack of vitamin D were more at risk of developing severe COVID-19," said Andrea Giustina, President of ESE. He continued, "Therefore, disciplines that work in the prevention, such as endocrinology, can focus on creating a healthier population, which can be important in the preparation for pandemics like COVID-19."

The need to address the links between endocrinology and COVID-19 has not gone unnoticed by policymakers. At the e-ECE opening ceremony, John Ryan, Director of public health, country knowledge and crisis management at the Directorate General for Health and Food Safety (DG SANTE) of the European Commission said, "there is a huge issue regarding non-communicable diseases and the EU is investing heavily together with Member States in trying to find effective ways to prevent it, such as the Farm2Fork Strategy of the EU4Health program."

COVID-19 incidence higher for those with underlying endocrine conditions

There is evidence that people with underlying endocrine conditions such as diabetes, obesity or autoimmune thyroid disease, face an increased risk of infection from COVID-19. In fact, vitamin D deficiency makes people more vulnerable to infection and may increase lung damage. In addition, recent studies show that certain underlying conditions, associated with exposure to endocrine-disrupting chemicals (EDCs), are exacerbating the effects of COVID-19 in vulnerable populations.

Endocrine conditions lead to worse outcomes for COVID-19

It has been proven that people suffering from underlying endocrine-related diseases, who are infected by COVID-19 are more likely to suffer severe symptoms, be admitted to intensive care units (ICU) as well as have an increased risk of death. For instance, in a study by Matteo Rottoli, obesity was shown to be a risk factor for respiratory failure, admission to the ICU and death among COVID-19 patients. In fact, patients with a body mass index (BMI) over 35kg/m2 had a dramatically increased risk of death.

Moreover, endocrine systems could suffer in the long term from the impact of COVID-19, since the hormone system is the key regulator of body weight, energy expenditure and energy (food) intake. In fact, COVID-19 is associated with anorexia, dysgeusia, dysfunction of gastrointestinal absorption and severe weight loss, mostly from muscle mass.

Urgent policy attention is needed to address these interlinkages

The European Society of Endocrinology (ESE) has stated in a COVID-19 and endocrinology position statement that we need urgent policy attention to address the structural factors and underlying conditions that render populations vulnerable and exacerbate healthcare crises such as the COVID-19 pandemic. The upcoming EU4Health strategy needs a strong endocrine and metabolic element to achieve its objectives. Therefore, it is needed to focus on the following demands: an increase in research funding for the relationship between COVID-19 and hormones, a coordinated effort for global surveillance, new models of patient management and increased collaboration between countries, policymakers and other stakeholders.

'COVID-19 and endocrine diseases - a statement from the European Society of Endocrinology' (23 March 2020).
ESE decalogue for endocrinologists in the COVID-19 pandemic
COVID 19 statement from the ESE President
ESE webinar series ESE Talks: Endocrine Conditions in the COVID-19 Era (7 May 2020).
European Journal of Endocrinology free review series: 'Endocrinology in the time of COVID-19' (21 April 2020).
ESE and ENDO-ERN launch initiative to collect data on patients with rare endocrine conditions and COVID-19.
ESE position statement on COVID-19 and endocrinology

European Society of Endocrinology

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to